Knight Therapeutics Inc KHTRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 98.23M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 36.63
- Price/Sales
- 1.87
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 1.20%
Company Profile
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and commercializing pharmaceuticalproducts. and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Latin America and select international markets. The company finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights. Geographically, the company generates revenue from Brazil, Canada, Colombia, Argentina, Mexico, Rest of LATAM, and Others, with the majority revenue generated from the Brazil region.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 830
- Website
- https://www.gud-knight.com
Valuation
|
Metric
|
KHTRF
|
|---|---|
Price/Earnings (Normalized) | 36.63 |
Price/Book Value | 1.30 |
Price/Sales | 1.87 |
Price/Cash Flow | 10.40 |
Price/Earnings
KHTRF
Financial Strength
|
Metric
|
KHTRF
|
|---|---|
Quick Ratio | 1.45 |
Current Ratio | 2.28 |
Interest Coverage | 2.56 |
Quick Ratio
KHTRF
Profitability
|
Metric
|
KHTRF
|
|---|---|
Return on Assets (Normalized) | 2.06% |
Return on Equity (Normalized) | 2.79% |
Return on Invested Capital (Normalized) | 3.09% |
Return on Assets
KHTRF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|&MgQhzc% | LOCK|^YT$ | $68B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|Yv?V@kw< | LOCK|!?^t | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|FLS>b& | LOCK|z$ | $40B | |||
| Zoetis Inc Class A
ZTS
| LOCK|mR@nX>R | LOCK|p?& | $30B | |||
| Viatris Inc
VTRS
| LOCK|rY<?&<Y | LOCK|lV | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|$S> | LOCK|>&P | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Zp#j<^ | LOCK|L? | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|HpjSMl | LOCK|J&! | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|n!>!>MN | LOCK|s$$P | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|LScg>t | LOCK|!T | $2B |
United States